跳至主要内容
临床试验/NCT00343070
NCT00343070已完成2 期

Functional Neuroimaging in Depression: Longitudinal Study of PET Metabolism in Correlation With Changes in Attentional Bias, Autobiographical Memory, Future Fluency and Facial Recognition in Depressed Patients Treated With Escitalopram.

University Hospital, Ghent4 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2007年3月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
4
主要终点
Brain metabolism

研究概览

简要总结

Oral administration of escitalopram during 8 weeks; PET scan with 18F-FDG at inclusion and after 8 weeks

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Major Depression, Depressive episode, following DSM-IV criteria
  • MADRS-score > 25
  • Age: 18-65 yrs
  • Medication-free or anti-depressant wash-out 7 days (for fluoxetine: 6 weeks)
  • Lorazepam 1mg or zolpidem 10mg are allowed

排除标准

  • Suicidality
  • Bipolar disorder, following DSM-IV criteria
  • Psychotic symptoms
  • Substance abuse
  • Personality disorder, following DSM-IV criteria
  • Cognitive dysfunction due to trauma capitis or dementia
  • Diabetes mellitus
  • Women without contraceptive protection, with pregnancy or breast feeding
  • Pharmacological treatment or ingestion of substance that can influence cerebral perfusion less than a month before inclusion
  • IQ below 80
  • Conditions not compatible with SPC

结局指标

主要结局

Brain metabolism

次要结局

  • Cognitive functions
  • Efficacy scales (mood, anxiety, anger and hopelessness)

研究者

申办方类型
Other

研究点 (4)

Loading locations...

相似试验